Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder

ClinicalTrials.gov ID: NCT00196404

Public ClinicalTrials.gov record NCT00196404. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder

Study identification

NCT ID
NCT00196404
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Duramed Research
Industry
Enrollment
800 participants

Conditions and interventions

Interventions

  • DR-3001a Drug
  • DR-3001b Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2004
Primary completion
Nov 30, 2006
Completion
Nov 30, 2006
Last update posted
Aug 19, 2012

2004 – 2006

United States locations

U.S. sites
46
U.S. states
24
U.S. cities
45
Facility City State ZIP Site status
Duramed Investigational Site Birmingham Alabama 35209
Duramed Investigational Site Huntsville Alabama 35801
Duramed Investigational Site Mobile Alabama 36608
Duramed Research Site Phoenix Arizona 85015
Duramed Research Site Tucson Arizona 85712
Duramed Investigational Site Little Rock Arkansas 72205
Duramed Investigational Site San Diego California 92108
Duremed Research Site San Diego California 92108
Duramed Investigational Site Aurora Colorado 80012
Duramed Research Site Colorado Springs Colorado 80909
Duramed Investigational Site Denver Colorado 80220
Duramed Investigational Site Waterbury Connecticut 06708
Duramed Investigational Site Aventura Florida 33180
Duramed Research Site Gainesville Florida 32607
Duramed Investigational Site Decatur Georgia 30034
Duramed Research Site Sandy Springs Georgia 30328
Duramed Investigational Site Boise Idaho 83712
Duramed Investigational Site Boise Indiana 83705
Duramed Investigational Site Evansville Indiana 47714
Duramed Investigational Site Fort Wayne Indiana 46825
Duramed Investigational Site Indianapolis Indiana 46202
Duramed Investigational Site Jeffersonville Indiana 47130
Duramed Investigational Site Meridian Indiana 83642
Duramed Investigational Site Shreveport Louisiana 71106
Duramed Investigational Site Jackson Mississippi 39202
Duramed Investigational Site Lebanon New Hampshire 03756
Duramed Investigational Site Edison New Jersey 08837
Duramed Investigational Site Livingston New Jersey 07039
Duramed Investigational Site Moorestown New Jersey 08057
Duramed Investigational Site Williamsville New York 14221
Duramed Investigational Site Portland Oregon 97210
Duramed Investigational Site Lancaster Pennsylvania 17604
Duramed Investigational Site Philadelphia Pennsylvania 19114
Duramed Investigational Site Providence Rhode Island 02904
Duramed Investigational Site Charleston South Carolina 29425
Duramed Investigational Site Jackson Tennessee 38305
Duramed Investigational Site Memphis Tennessee 38120
Duramed Investigational Site Nashville Tennessee 37232
Duramed Investigational Site Dallas Texas 75234
Duramed Research Site Houston Texas 77024
Duramed Investigational Site San Antonio Texas 78229
Duramed Research Site Waco Texas 76712
Duramed Investigational Site Salt Lake City Utah 84124
Duramed Investigational Site Seattle Washington 98105
Duramed Research Site Tacoma Washington 98405
Duramed Investigational Site Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00196404, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 19, 2012 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00196404 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →